Market Listing. From the Signing Date through the Closing Date, Company shall use all commercially reasonable efforts to (i) maintain the listing and trading of the Common Stock on the Nasdaq Stock Market and (ii) effect the listing of the Shares on the Nasdaq Stock Market, including submitting the LAS to the Nasdaq Stock Market no later than fifteen (15) calendar days prior to the Closing Date.
Appears in 4 contracts
Samples: Stock Purchase Agreement (Voyager Therapeutics, Inc.), Stock Purchase Agreement (Voyager Therapeutics, Inc.), Stock Purchase Agreement (Neurocrine Biosciences Inc)
Market Listing. From the Signing Date through the Closing DateClosing, Company shall use all commercially reasonable efforts to (i) maintain the listing and trading of the Common Stock Shares on the Nasdaq Stock Market and (ii) effect the listing of the Purchased Shares on the Nasdaq Stock Market, including submitting the LAS to the Nasdaq Stock Market no later than fifteen (15) calendar days prior to the Closing DateMarket.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Xenon Pharmaceuticals Inc.), Share Purchase Agreement (Xenon Pharmaceuticals Inc.)
Market Listing. From the Signing Date through the Closing DateClosing, Company shall use all commercially reasonable efforts to (i) maintain the listing and trading of the Common Stock Shares on the Nasdaq Stock Market and (ii) effect the listing of the Purchased Shares on the Nasdaq Stock Market, including submitting submitting, if required, the LAS to the Nasdaq Stock Market no later than fifteen (15) calendar days prior to the Closing DateMarket.
Appears in 2 contracts
Samples: Share Purchase Agreement (Xenon Pharmaceuticals Inc.), Share Purchase Agreement (Xenon Pharmaceuticals Inc.)
Market Listing. From the Signing Date date hereof through the Closing Date, Company shall use all commercially reasonable efforts to (ia) maintain the listing and trading of the Common Stock on the The Nasdaq Stock Global Select Market and (iib) effect the listing of the Shares on the The Nasdaq Stock Global Select Market, including submitting the LAS to the The Nasdaq Stock Market LLC no later than fifteen (15) calendar days prior to the Closing Date.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Achillion Pharmaceuticals Inc), Stock Purchase Agreement (Alnylam Pharmaceuticals, Inc.)
Market Listing. From the Signing Date date hereof through the Closing Date, Company shall use all commercially reasonable efforts to (ia) maintain the listing and trading of the Common Stock on the The Nasdaq Stock Global Select Market and (iib) effect the listing of the Shares on the The Nasdaq Stock Global Select Market, including submitting the LAS to the The Nasdaq Stock Market no later than fifteen (15) calendar days prior to the Closing DateLLC, if required.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Regeneron Pharmaceuticals, Inc.), Stock Purchase Agreement (Alnylam Pharmaceuticals, Inc.)
Market Listing. From the Signing Date date hereof through the Closing Date, Company shall use all commercially reasonable efforts to (ia) maintain the listing and trading of the Common Stock on the The Nasdaq Stock Global Market and (iib) effect the listing of the Shares on the The Nasdaq Stock Global Market, including submitting the LAS to the The Nasdaq Stock Market LLC no later than fifteen (15) calendar days prior to the Closing Date.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Entrada Therapeutics, Inc.), Stock Purchase Agreement (Macrogenics Inc)
Market Listing. From the Signing Date through the Closing Date, Company shall use all commercially reasonable efforts to (i) maintain the listing and trading of the Common Stock on the Nasdaq Stock Market and (ii) effect the listing of the Shares on the Nasdaq Stock Market, including submitting the LAS to the Nasdaq Stock Market no later than fifteen (15) calendar days prior to promptly following the Closing Datedate hereof.
Appears in 1 contract
Market Listing. From the Signing Date through the Closing Date, Company shall use all commercially reasonable efforts to (i) maintain the listing and trading of the Common Stock on the Nasdaq Stock Market and (ii) effect the listing of the Shares on the Nasdaq Stock Market, including submitting the LAS to the Nasdaq Stock Market no later than fifteen (15) calendar days prior in the event the Company determines that such a submission is required pursuant to the Closing Daterules and regulations of the Nasdaq Stock Market.
Appears in 1 contract
